News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CSL.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but don’t throw the baby out with the bathwater
News
ASX Large Caps: Shares up 4pc this week, market welcomes ‘dovish’ Bullock as next RBA governor
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall in first week of FY23 as Mach 7 scores biggest deal in its history
News
UBS says the best insurance against a recession is… probably insurance
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks up as Avita Medical gets US FDA green light
Experts
Adam Lawrance: Bifurcation and the five common investor biases driving markets
Health & Biotech
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall as CSL faces FX headwinds
News
ASX Large Caps: Relief rally for the ASX as US inflation cools; lithium stocks gain
Health & Biotech
ASX Health Stocks: Clarity to expand Phase 3 trial sites; CSL downgrades profit on FX headwinds
Experts
FREE WHELAN: Japan, India or China; And the best ASX bad stock list money can’t buy
News
Winter is Coming: How to build a defensive fortress around your heart and your ASX portfolio
News
ASX Large Caps: Health stocks surge on Budget funding, as focus now shifts to US CPI tonight
News
ASX Large Caps: Shares slip ahead of Easter break; RBA warns of ‘mortgage cliff’ in next 2 months
News
Boost for ASX healthcare sector as Neuren gets US FDA approval for drug to treats Rett Syndrome
Health & Biotech
Dr Boreham’s Crucible: With new blood at the top, can CSL continue its reign?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks drop 0.3% but reporting season gives cause for optimism
Health & Biotech